Cancer Meds Often Bring Big Out-Of-Pocket Costs For Patients, Report Finds

Kaiser Health News writes:Cancer patients shopping on federal and state insurance marketplaces often find it difficult to determine whether their drugs are covered and how much they will pay for them, the advocacy arm of the American Cancer Society says in a report that also calls on regulators to restrict how much insurers can charge patients for medications.

While the report found fairly broad coverage for prescription cancer medications, most insurance plans in the six states that were examined placed all or nearly all of the 22 medications studied into payment “tiers” that require the biggest out-of-pocket costs by patients, the American Cancer Society Cancer Action Network said. Those drugs include some well-known treatments, such as Gleevec for certain types of leukemia and Herceptin for breast cancer, and even some generics.

Read more:

• American Cancer Society: ACS CAN Examination of Cancer Drug Coverage and Transparency in the Health Insurance Marketplaces (PDF)
• Kaiser Health News: http://khn.org/news/cancer-meds-often-bring-big-out-of-pocket-costs-for-patients-report-finds/